Constellation Pharmaceuticals, Inc. announced that Dr. Elizabeth G. Tréhu and Steven L. Hoerter have been appointed to its Board of Directors. Dr. Tréhu is a hematologist /oncologist with 16 years of management experience at several biopharmaceutical companies. Tréhu is currently Chief Medical Officer at Jounce Therapeutics and previously served as Chief Medical Officer at Promedior. Since early 2016, Mr. Hoerter has served as Chief Commercial Officer of Agios Pharmaceuticals, where he built and leads the team responsible for the commercialization of the company’s portfolio of medicines for oncology and rare genetic diseases. He has more than 25 years of global pharmaceutical and biotechnology experience, having held sales and marketing roles at Roche, Genentech, Chiron and Eli Lilly.